Načítá se...
The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions
The validated EndoPredict assay is a novel tool to predict the risk of metastases of patients with estrogen receptor positive, HER2 negative breast cancer treated with endocrine therapy alone. It has been designed to integrate genomic and clinical information and includes clinico-pathological factor...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3694878/ https://ncbi.nlm.nih.gov/pubmed/23826382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0068252 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|